Different Concentrations of Potassium Nitrate in In-office Tooth Bleaching Sensitivity
Launched by UNIVERSIDADE FEDERAL DO AMAZONAS · Oct 25, 2017
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
For this study, 56 volunteers who had an equal allocation rate between the groups (G1-control and G2-experimental) were selected for this study. Both gels act in the same way, the difference between them is the concentration. In both groups, the different desensitizing gels were applied to the vestibular surface of the anterior superior teeth with the aid of a tray, remaining in position according to the time specified by the manufacturers. In the control group, a gel based on 5% potassium nitrate and 2% sodium fluoride was used, while in the experimental group, the gel was based on 3% pota...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged 18 years and older, of both sexes, who had to present at least six upper anterior teeth free of caries and restorations on the vestibular face, and at least one central or canine incisor showing coloration A2 or darker, evaluated in comparison to a visual value-oriented color scale of the teeth (Vita Classical®, Vita-Zahnfabrik- Germany).
- • Prior to the interventions, the signing of each participant's free and informed consent form (Appendix I) was obtained after due explanations about the nature of the study and the possible risks of the proposed treatments.
- Exclusion Criteria:
- • The individuals excluded from the study were: users of fixed orthodontic appliances, patients with periodontal disease, pregnant or lactating, with severe intrinsic stains on the teeth (spots on the use of tetracycline, fluorosis and depolluted teeth), consuming any Anti-inflammatory and anti-oxidant drugs, using desensitizing dentifrice and participants with previous history of SD or any associated pathology (bruxism, gingival recession, non-carious lesion with dentin exposure).
About Universidade Federal Do Amazonas
The Universidade Federal do Amazonas (UFAM) is a leading academic institution in Brazil, dedicated to advancing research and education in various fields, including health sciences. With a strong commitment to innovation and community engagement, UFAM actively conducts clinical trials aimed at addressing pressing health challenges, particularly those affecting the Amazon region. The university's multidisciplinary approach fosters collaboration among researchers, healthcare professionals, and local communities, ensuring that clinical studies are not only scientifically rigorous but also culturally relevant and ethically conducted. Through its clinical research initiatives, UFAM strives to contribute to the improvement of public health outcomes and the advancement of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Leandro M Martins, doctorate
Study Chair
amazon federal university
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials